Tracie Oliver, Chief Commercial Officer at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 17,850 shares at $35.31 ($630K) on 2023-07-03, disclosed to the SEC on 2023-07-06.
Open-market sale of $630k ARWR by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.31 | 8,925 | $315K | 50.0% |
| 2 | $35.31 | 8,925 | $315K | 50.0% |
| Total | $35.31 avg | 17,850 | $630K | 100% |
| Filing → |